The objective of this course is to provide a thorough grounding in the conduct of randomized clinical trials to researchers and health professionals interested in developing competence in the planning, design, and execution of randomized clinical trials involving behavioral interventions.
The curriculum will enable participants to:
- Describe the principles underlying the conduct of unbiased clinical trials
- Identify the unique challenges posed by behavioral randomized clinical trials (RCTs)
- Evaluate RCT designs in terms of their appropriateness to scientific and clinical goals
- Select appropriate strategies for enrollment, randomization, and retention of participants
- Understand methods for monitoring, coordinating, and conducting RCTs
- Develop strategies for appropriate statistical analyses of RCT data
- Evaluate the quality of behavioral RCTs and interpret their results
- Design an RCT as part of a working group on a specific topic.
Dr. Sterman discusses systems approaches in public health, including the concepts of policy resistance, implementation feedbacks, and model boundaries and explores how these ideas can be applied to effect change in a complex system. He includes examples from healthcare and public health such as implementation of formulary drug lists and SARS epidemic modeling.
Dr. McLeroy discusses adoption of systems methodology, including multiple levels of analysis, utility for identifying points of change, testing models against reality, and applications to program evaluation and various research designs, including community-based participatory research and randomized clinical trials.
The National Cancer Institute is hosting this training institute to provide participants with a thorough grounding in conducting D&I research with a specific focus on cancer, across the cancer control continuum. In 2020, the institute will use a combination of online coursework (six modules with related assignments) and a 2-day in-person training to be held August 3 and 4, 2020, at the NCI campus in Bethesda, MD. Faculty and guest lecturers consist of leading experts in D&I theories, models, and frameworks; intervention fidelity and adaptation; stakeholder engagement and partnership for D&I; research methods and study designs for D&I; and measures and outcomes for D&I. This training institute has been adapted from the broader Training Institute for Dissemination and Implementation Research in Health (TIDIRH), organized by NIH and the VA over the past nine years.
This training is designed for investigators at any career stage interested in conducting D&I research with a focus on the cancer control continuum. There is no cost associated with the training. Invited participants are required to cover related travel expenses to the Washington D.C. area for the in-person meeting. More answers to common questions can be found on the site FAQ.
Dr. Laura Damschroder’s webinar introduces Consolidated Framework for Implementation Research (CFIR) and its application in a series of studies highlighting its use to guide data collection, analyses, and its potential for syntheses; and to guide tailoring of implementation strategies.
Dr. Greg Aarons’ webinar introduces the Exploration, Preparation, Implementation, Sustainment (EPIS) framework and its application in a series of studies highlighting its use to guide data collection, analyses, and its potential for syntheses; and to guide tailoring of implementation strategies.
Dr. Abe Wandersman’s webinar continued a series of presentations and discussions about the development and application of frequently-used implementation research models and frameworks. Dr. Wandersman, key developer of the Interactive Systems Framework (ISF), discusses the genesis of the framework, key terms and concepts, and then presents projects that have used the ISF as a core lens to support planning and study of evidence-based practice implementation.
Implementation science methodologies, approaches, and tools have a great interdisciplinary applicability. Dr. Alice Ammerman’s webinar discusses what new (and "new to") D&I investigators need to know to succeed in this burgeoning field.